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stimulation. More importantly, Foxj1 prevents spontane-Another Fork in the Road:
ous activity of the pleiotropic transcription regulator NF-Foxo3a Regulates B in resting T cells by controlling the expression of
IB, a protein that binds to NF-B and maintains it inNF-B Activation
an inactive cytosolic form (Lin et al., 2004b).
As reported in this issue of Immunity, the observation
that Foxj1 represses NF-B activity prompted Lin et al.
Previous studies have implicated the transcription fac- to examine whether FoxOs modulate NF-B activity.
tor FoxO3a in apoptosis induction. Thus, it comes as They found that Foxo3a, but not Foxm1 or Foxq1, could
a surprise in this issue of Immunity that lymphoproli- suppress spontaneous activity on a cotransfected NF-
ferative disease in Foxo3a-deficient mice may be due B-luciferase reporter construct. Moreover, Foxo3a ac-
to T cell hyperactivity instead of cell death defects. tivity was dramatically decreased in naive T cells from
Lin and colleagues provide important new evidence lupus-prone strains compared to nonautoimmune
mouse strains. Thus, Foxo3a might suppress NF-B-that disease development is associated with NF-B
induced autoimmunity. As Foxo3a is the predominanthyperactivation in T cells.
Foxo expressed in peripheral lymphoid organs, the au-
thors generated Foxo3a-deficient mice to test whetherThe FoxO (Forkhead box-containing protein, o subfam-
Foxo3a regulates T cell homeostasis in vivo. Althoughily) group of Forkhead/winged helix transcription factors
mice were initially healthy except for premature ovarianis comprised of at least four structurally related mem-
failure, they developed a multiorgan infiltrative, lympho-bers: FoxO1 (FKHR), FoxO3a (FKHRL1), FoxO4 (AFX),
proliferative disease, with T helper hyperactivity andand FoxO6. In mammals, the FoxO subfamily regulates
expansion.key cellular processes, including cell cycle progression
One possible explanation for the lymphoproliferative(p27kip, Rb2/p130, cyclin B and D, polo-like kinases, and
disease observed in Foxo3a-deficient mice could bep21cip1), DNA repair (GADD45), detoxification of reactive
impaired lymphocyte apoptosis. This picture is seen inoxygen species (Mn superoxide dismutase and cata-
lpr or gld mice having defective Fas or Fas Ligand ex-lase), and apoptosis (Fas Ligand, Bim, TRAIL, and
pression. This explanation was plausible in light of sub-TRADD) (Accili and Arden, 2004; Tran et al., 2003). FoxO
stantial literature showing that FoxO binding sites existfactors share a core consensus DNA binding sequence
in promoters for proapoptotic genes such as Fas Ligandand can activate transcription either directly or via other
and Bim. Also, PI3K-dependent FoxO regulation is asso-interacting cofactors. FoxO1, FoxO3a, and FoxO4 are
ciated with proapoptotic gene expression and deathnegatively regulated by the phosphoinositide 3-kinase
(Tran et al., 2003). Those studies were, however, pri-(PI3K)-Akt/PBK (protein kinase B) signaling pathway. In
marily done in overexpression systems, rendering theirthe absence of environmental signals or growth factors,
physiologic significance less certain. When Foxo3a-
FoxO members localize to the nucleus. After PI3K-induced
deficient cells were evaluated, Lin et al. failed to identify
activation of the serine/threonine kinase Akt, FoxOs are
any apoptosis defect, leading the authors to conclude
rapidly phosphorylated. Phosphorylated FoxOs bind to that dysregulated T cell proliferation and/or activation
14-3-3 chaperones, which sequester FoxO within the was instead primarily responsible for the lymphoprolifer-
cytosol and prevent reentry into the nucleus, leading to ative disease.
functional inactivation. More recently, FoxO3a has been The study by Lin et al. in this issue of Immunity now
shown to be regulated through Akt-independent path- provides evidence that Foxo3a is critical for lymphoid
ways, such as phosphorylation by IB kinase, which leads homeostasis by modulating NF-B activity. In addition
to ubiquitin-dependent degradation (Hu et al., 2004) or to their functional hyperactivity, T cells from Foxo3a-
NAD-dependent deacetylation (Brunet et al., 2004; Motta deficient mice displayed markedly increased spontane-
et al., 2004). Thus, multiple mechanisms can precisely ous NF-B activity concomitant with decreased IB,
regulate FoxO transcriptional activity. IB, and Foxj1 expression. However, the immediate
PI3K is crucial for balanced lymphoid homeostasis. targets of Foxo3a for repressing NF-B activity remain
Unrestrained PI3K prevents T cell apoptosis, thereby a mystery. IB and IB lack Foxo binding promoter
predisposing to autoimmunity and leukemia. Conversely, sequences and the authors were unable to demonstrate
impaired PI3K activity causes immunodeficiency (Ok- transactivation by Foxo3a. The overlapping phenotypes
kenhaug and Vanhaesebroeck, 2003). PI3K downregu- suggest that some of the effects of Foxo3a deficiency
lates FoxO during antigen receptor stimulation of T and may indirectly result from decreased Foxj1 expression. It
B cells (Lin et al., 2004a [this issue of Immunity]; Stahl is known that FoxOs and other Foxs can form complexes
et al., 2002; Yusuf et al., 2004). Thus, PI3K may govern together with additional signaling molecules to exert
lymphoid homeostasis by modulating FoxO activity, but transcriptional effects (Seoane et al., 2004). Thus, it is
what lies downstream of FoxOs has emerged as an possible that Foxo3a and Foxj1 could cooperatively bind
important question. An initial clue was provided by Stan- and recruit different coactivators or corepressors to
ford Peng’s laboratory with the identification of the tran- control NF-B.
scription factor Foxj1 as an important repressor of T cell During an individual’s lifespan, slight perturbations in
activation and autoreactivity. Like FoxO, Foxj1 is active the rates of lymphocyte generation versus lymphocyte
death can result in the gradual accumulation of lympho-in naive T and B cells and decreases after antigenic
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both eliminate tolerance and impair the clearance of theSHIP, TGF-,
pyrogen from the blood (Beeson, 1947b). Noting the lackand Endotoxin Tolerance of serospecificity (tolerance prevented a response to
pyrogens prepared from almost any gram-negative or-
ganism) and the recovery of competence to mount a
febrile response within a few weeks after pyrogen injec-
Research into the biology of endotoxin (aka lipopoly- tions were terminated (a time point at which antibodies
saccharide; LPS) began well over 100 years ago (Pfeif- against capsular polysaccharides were still abundant in
fer, 1892) and has had many unexpected turns. The serum), Beeson and others discounted a role for anti-
phenomenon of endotoxin tolerance was among these bodies against the pyrogen in the development of endo-
and has engendered immense curiosity over the years. toxin tolerance, considering instead that a cellular
Sly and colleagues (this issue of Immunity) have taken mechanism was at play. Later workers concluded that
an important step toward understanding the phenom- “endogenous pyrogens” (i.e., pyrogenic cytokines) were
enon of endotoxin tolerance and have enhanced our produced largely by mononuclear phagocytic cells in
comprehension of LPS signaling as a whole by demon- response to LPS; hence, it made sense to think that the
strating that the cytosolic phosphatase SHIP is re- ability to develop tolerance was an inherent property of
quired to permit the development of an LPS-refractory these cells. The fact that LPS tolerance could be ob-
state in macrophages and mice. served in cultured macrophages was a commonplace
observation that reinforced this view. The discoveries
Endotoxin tolerance was a phenomenon first noticed in that TNF (Beutler et al., 1985) and interferon- (Karaghio-
humans rather than in animals. In the 1930s and 1940s, soff et al., 2003) mediate much of the toxicity of LPS
typhoid vaccine was administered to patients with neu- have, in turn, given relevant endpoints to follow in as-
rosyphilis to induce fever, which was known to slow sessing LPS tolerance both in vivo and in vitro.
the progress of T. pallidum infection within the central The cellular mechanism for endotoxin tolerance is of
nervous system. With repeated administration, the vac- obvious interest, because dampening the LPS response
cine showed progressive loss of efficacy as a pyrogen, may have important clinical utility, most notably in se-
and an escalation of dose was required to achieve a vere gram-negative infections. Hence, the biochemical
therapeutic effect: a phenomenon closely investigated basis of the “natural” inhibition of LPS signaling that
by Beeson (Beeson, 1947a). He established a rabbit occurs in mononuclear phagocytes has attracted much
model of tolerance and concluded that tolerance arose attention. But for many years, the biochemical basis
from an interaction between LPS and reticuloendothelial of LPS tolerance remained obscure and only now is a
cells, since “reticuloendothelial blockade” with Thoro- detailed understanding of the phenomenon beginning
to emerge.trast (colloidal thorium dioxide) or trypan blue could
